share_log

Enliven Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(6.8%),Peter Harwin(6.8%), etc.

SEC ·  Nov 15 05:23
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more